Clinical trials
Breast Cancer Lymphedema trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 4 |
| Koya Medical, Inc. | 3 |
| Tactile Medical | 2 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Stanford University | 1 |
| Texas Woman's University | 1 |
| University Hospital, Basel, Switzerland | 1 |
| University of Florida | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Cancer Lymphedema | 15 |
| Lymphedema | 7 |
| Breast Neoplasms | 5 |
| COVID-19 | 1 |
| Edema | 1 |
| Lymphadenopathy | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.